Technology | 2009.10.09
Medtronic Launches Improved Delivery System Internationally for Minimally Invasive Treatment of Thoracic Aortic Aneurysms
MINNEAPOLIS--(BUSINESS WIRE)--Adding to its market-leading portfolio of innovative medical technology for endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), announced today the CE (Conformité Européene) mark and international launch of the Captivia Delivery System for the Valiant® Thoracic Stent Graft, a minimally invasive treatment for aneurysms and other lesions of the thoracic aorta. The Captivia Delivery System features tip capture for enhanced control of the Vali
For more information, please visit
http://www.businesswire.com/news/home/20091008005999/en
Follow us on
Instagram is adding automatic in-app text translation - The Verge views: 1531
Instagram is adding automatic in-app text translation - The Verge views: 1500